Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol Methods ; 468: 55-60, 2019 05.
Article in English | MEDLINE | ID: mdl-30880262

ABSTRACT

Antibody-based therapeutics are powerful tools to treat disease. While their mechanism of action (MOA) always involves binding to a specific target via the Fab region of the antibody, the induction of effector functions through the Fc region of the antibody is equally important for antibody therapeutics designed to deplete tumor cells. By binding of the Fc region to Fc gamma receptors (FcγRs) on the surface of immune cells or complement factors, antibody therapeutics exert effector functions such as antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC), both of which induce target cell death and aid in the efficacy of treatment. Another major Fc effector function is antibody-dependent cellular phagocytosis (ADCP). ADCP is the mechanism by which antibody-opsonized target cells activate the FcγRs on the surface of macrophages to induce phagocytosis, resulting in internalization and degradation of the target cell through phagosome acidification. ADCP has been implicated as a major MOA of several biologics, but this activity is difficult to measure in in vitro. Most assays measure the association of target cells and macrophages; however, co-localization can represent cell attachment rather than internalization. Here, we describe the development of a novel method to accurately measure ADCP activity. By labeling target cells with a pH sensitive dye that only fluoresces in mature phagosomes, the ADCP activity of antibody therapeutics can be accurately quantitated via flow cytometry.


Subject(s)
Antibodies, Monoclonal, Humanized/pharmacology , Antineoplastic Agents, Immunological/pharmacology , Cytotoxicity, Immunologic/drug effects , Flow Cytometry , Fluorescent Dyes/metabolism , Macrophages/drug effects , Neoplasms/drug therapy , Phagocytosis/drug effects , Phagosomes/drug effects , Rituximab/pharmacology , Antibodies, Monoclonal, Humanized/metabolism , Cell Line, Tumor , Glycosylation , Humans , Hydrogen-Ion Concentration , Macrophages/immunology , Macrophages/metabolism , Macrophages/pathology , Neoplasms/immunology , Neoplasms/metabolism , Neoplasms/pathology , Phagosomes/immunology , Phagosomes/metabolism , Phagosomes/pathology , Receptors, IgG/metabolism , Rituximab/metabolism
2.
Nat Commun ; 8(1): 321, 2017 08 22.
Article in English | MEDLINE | ID: mdl-28831039

ABSTRACT

Reactivating quiescent cells to proliferate is critical to tissue repair and homoeostasis. Quiescence exit is highly noisy even for genetically identical cells under the same environmental conditions. Deregulation of quiescence exit is associated with many diseases, but cellular mechanisms underlying the noisy process of exiting quiescence are poorly understood. Here we show that the heterogeneity of quiescence exit reflects a memory of preceding cell growth at quiescence induction and immediate division history before quiescence entry, and that such a memory is reflected in cell size at a coarse scale. The deterministic memory effects of preceding cell cycle, coupled with the stochastic dynamics of an Rb-E2F bistable switch, jointly and quantitatively explain quiescence-exit heterogeneity. As such, quiescence can be defined as a distinct state outside of the cell cycle while displaying a sequential cell order reflecting preceding cell growth and division variations.The quiescence-exit process is noisy even in genetically identical cells under the same environmental conditions. Here the authors show that the heterogeneity of quiescence exit reflects a memory of preceding cell growth at quiescence induction and immediate division history prior to quiescence entry.


Subject(s)
Algorithms , Cell Cycle/physiology , Cell Proliferation/physiology , Models, Biological , Animals , Cell Cycle/drug effects , Cell Cycle/genetics , Cell Division/drug effects , Cell Division/genetics , Cell Division/physiology , Cell Line , Cell Proliferation/drug effects , Cell Proliferation/genetics , Cell Size , Culture Media/pharmacology , Culture Media, Serum-Free/pharmacology , E2F Transcription Factors/genetics , E2F Transcription Factors/metabolism , Rats , Retinoblastoma Protein/genetics , Retinoblastoma Protein/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...